Although the precise underlying mechanism involved in the reduction of colonic IL-38 during the development of CRC is unclear, it is speculated that compromised intestinal mucosal immunity might contribute to the disturbance of the balance between pro- and anti-inflammatory cytokines in the colon (27) within the susceptible cohort (60). Here, IL1F10 is linked to colorectal carcinoma.